Calmodulin (CaM) may function as a regulatory subunit of ryanodine receptor (RYR) channels, modulating both channel activation and inhibition by Call; however, mechanisms underlying differences in CaM regulation of the RYR isoforms expressed in skeletal muscle (RYR1) and cardiac muscle (RYR2) are poorly understood. Here we use a series of CaM mutants deficient in Call binding to compare determinants of CaM regulation of the RYR1 and RYR2 isoforms. In submicromolar Call, activation of the RYR1 isoform by each of the single-point CaM mutants was similar to that by wild-type apoCaM, whereas in micromolar Ca2+, RYR1 inhibition by Ca2+CaM was abolished by mutations targeting CaM's C-terminal Call sites. In contrast to the RYR1, no activation of the cardiac RYR2 isoform by wild-type CaM was observed, but rather CaM inhibited the RYR2 at all Call concentrations (100 nM to 1 mm). Consequently, whereas the apparent Call sensitivity of the RYR1 isoform was enhanced in the presence of CaM, the RYR2 displayed the opposite response (RYR2 Ca2+ EC50 increased 7-10-fold in the presence of 5 muM wild-type CaM). CaM inhibition of the RYR2 was nonetheless abolished by each of four mutations targeting individual CaM Call sites. Furthermore, a mutant CaM deficient in Call binding at all four Call sites significantly activated the RYR2 and acted as a competitive inhibitor of RYR2 regulation by wild-type Ca2+CaM. We conclude that Call binding to CaM determines the effect of CaM on both RYR1 and RYR2 channels and that isoform differences in CaM regulation reflect the differential tuning of Ca2+ binding sites on CaM when bound to the different RYRs. These results thus suggest a novel mechanism by which CaM may contribute to functional diversity among the RYR isoforms.
机构:
Jikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Yamazawa, Toshiko
Ogawa, Haruo
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokyo, Inst Quantitat Biosci, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Ogawa, Haruo
Murayama, Takashi
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Dept Pharmacol, Sch Med, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Murayama, Takashi
Yamaguchi, Maki
论文数: 0引用数: 0
h-index: 0
机构:
Jikei Univ, Dept Mol Physiol, Sch Med, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Yamaguchi, Maki
Oyamada, Hideto
论文数: 0引用数: 0
h-index: 0
机构:
Showa Univ, Sch Med, Dept Pharmacol, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Oyamada, Hideto
Suzuki, Junji
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo, Japan
Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USAJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Suzuki, Junji
Kurebayashi, Nagomi
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Dept Pharmacol, Sch Med, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Kurebayashi, Nagomi
Kanemaru, Kazunori
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo, Japan
Nihon Univ, Div Cellular & Mol Pharmacol, Sch Med, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Kanemaru, Kazunori
Oguchi, Katsuji
论文数: 0引用数: 0
h-index: 0
机构:
Showa Univ, Sch Med, Dept Pharmacol, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Oguchi, Katsuji
Sakurai, Takashi
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Dept Pharmacol, Sch Med, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
Sakurai, Takashi
Iino, Masamitsu
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo, Japan
Nihon Univ, Div Cellular & Mol Pharmacol, Sch Med, Tokyo, JapanJikei Univ, Dept Mol Physiol, Sch Med, Tokyo, Japan
机构:
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSWSchool of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW